Prince JB, Wilens TE, Biederman J et al. (1996), Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry 35(5):599-605.
Research Unit on Pediatric Psychopharmacology (RUPP) Anxiety Study Group (2001), Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 344(17):1279-1285 [see comments].
Rush CR, Baker RW, Wright K (1999), Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology (Berl) 144(3):220-233.
Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P et al. (2001), Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology 44(3):139-149.
Saletu-Zyhlarz GM, Anderer P, Arnold O, Saletu B (2003), Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled release formulation in depressed outpatients. Neuropsychobiology 48(4):194-208.
Scheffer RE, Kowatch RA, Carmody T, Rush AJ (2005), Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 162(1):58-64.
Simeon JG, Ferguson HB, Knott V et al. (1992), Clinical, cognitive, and neuropsychological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31(1):29-33.
Smits MG, van Stel HF, van der Heijden K et al. (2003), Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo controlled trial. J Am Acad Child Adolesc Psychiatry 42(11): 1286-1293.
